Cite
MLA Citation
Chun-Yan Lan et al.. “Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.” Lancet oncology, vol. 19, no. 9, 2018, pp. 1239–1246. http://access.bl.uk/ark:/81055/vdc_100066658615.0x000013